Study: Byambasuren et al. (2023)
Summarised by: Shaima Begom
Current observational studies suggest that COVID-19 vaccination may improve symptoms and support recovery from Long Covid, although higher-quality clinical trials are needed to confirm these findings.
• Data from 10 observational studies suggested that covid-19 vaccination before infection trends with protection from long covid. 5 studies also suggested that vaccination after infection may help long covid symptoms and recovery.
• The observational studies were found to have a moderate to critical risk of bias, hence this study was unable to conclusively answer the question of whether covid-19 vaccines can prevent or treat long covid.
• More controlled observational studies and clinical trials are needed to robustly demonstrate the benefit of vaccination on long covid outcomes.
| Strengths | Limitations |
| Wide search for studies including published, pre-print and un-published articles and public health reports. A rigorous inclusion criteria used to select studies. | Only observational studies included, with no controlled trial data available. |
| Critical assessment of the risk of bias in included studies. | High chance of bias calculated from the studies, reducing the strength of the evidence. |
| Identification of the lack of high quality data from randomised clinical trials to determine the effect of vaccination on long covid outcomes and recovery. | Inconsistency between studies, preventing meaningful meta-analysis. |
• This study is important for healthcare workers to highlight that covid-19 vaccination may be associated with better outcomes in long covid.
• This study suggests that covid-19 vaccines may support disease recovery in long covid patients. This data trend is particularly important to consider in the case of vaccine hesitancy in long covid patients.
• This study highlights the need for further research, including robust comparative studies and clinical trials to clearly demonstrate the benefit of covid vaccination on preventing and treating long covid. Demonstrating such a benefit would inform public health measures and impact vaccine uptake.
Current observational studies suggest that covid-19 vaccines may improve symptoms and support recovery from long covid, highlighting the need for future controlled clinical trials to clearly demonstrate these beneficial effects.
More than 1 in 10 of 1,496 US healthcare personnel reported the same moderate or severe symptom at both three and six months after COVID-19. Read the findings, limitations and what they may mean for SHH-UK readers.
Join SHH-UK’s online support groups for healthcare workers with Long Covid this October and November. Connect, chat and share with others.
A large US study of almost 2,000 children and adolescents found that those meeting the research threshold for probable Long COVID were more likely to experience difficulties with grades, attention and participation with friends.